COMP <GO>
JHX vs TMO // EV/EBITDA & P/E VALUATION
James Hardie Industries plc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: JHX 4
— TMO 10
▲ EV/EBITDA & P/E VALUATION LEADER: JHX
LAST: $27.24 (+1.11%) • MKT CAP: $15.64B
valuation
21.1x
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
valuation
30.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (JHX VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | JHX | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 35.80% | 41.00% | -5.20 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.20% | 9.30% | -2.10 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 21.1x | 30.4x | -9.30 | JHX | /valuation <GO> |
| Free Cash Flow Yield | 1.32% | 2.40% | -1.08 | TMO | /fcf-yield <GO> |
| Operating Margin | 9.30% | 17.40% | -8.10 | TMO | /operating-margins <GO> |
| Net Profit Margin | 2.20% | 15.10% | -12.90 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 24.70% | 3.90% | +20.80 | JHX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.73 | 4.50 | -0.77 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 6.70% | +0.10 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.5 | 59.1 | +0.39 | JHX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.96 | 0.94 | +0.02 | JHX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 126.3x | 36.3x | +90.00 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $15.64B | $262.22B | -$246.58B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | JHX REV | TMO REV | JHX GROSS % | TMO GROSS % | JHX FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.84B | $44.56B | 35.8% | 44.0% | $205.9M | $6.29B |
| FY 2024 | $3.88B | $42.88B | 38.8% | 44.0% | $380.6M | $7.27B |
| FY 2023 | $3.94B | $42.86B | 44.0% | 44.0% | $737.1M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
JHX // BETA 0.96
TMO // BETA 0.94